Results 51 to 60 of about 5,988 (201)
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Background The prognostic benefit of revascularization for unprotected left main (LM) disease remains uncertain, as guideline endorsement of percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) precludes comparison with deferral, which is unlikely to be assessed in a randomized trial.
Marc Meller Bröchner +10 more
wiley +1 more source
Clinical and Applied Thrombosis/Hemostasis, 2023 A high rate of thromboembolism and a high risk of death have been reported regarding hospitalized patients with coronavirus disease 2019 (COVID-19). Recently, we noticed that clinicians in some comparative studies used direct oral anticoagulants (DOACs ...
Yong Tian MD +7 more
doaj +1 more source
Reimbursement and use of oral anticoagulants during 2014–2022 - A register-based study
Exploratory Research in Clinical and Social Pharmacy, 2023 Background: Vitamin K antagonists, warfarin in particular, have been the mainstay of anticoagulation therapy, but their use has declined in many countries since direct oral anticoagulants (DOACs) have entered the market. Objective: To examine utilization
Emma Aarnio +3 more
doaj +1 more source
Journal of Hospital Medicine, EarlyView.Abstract Health‐related social needs (HRSN) significantly influence patient outcomes, yet they are rarely integrated into point‐of‐care decision‐making. We developed a process to embed HRSN‐informed and HRSN‐targeted care recommendations directly into three electronic health record‐integrated high‐use clinical pathways—cirrhosis, diabetes, and ...
Karthik Warke Rohatgi +5 more
wiley +1 more source
Differential benefit risk assessment of DOACs in the treatment of venous thromboembolism: focus on dabigatran [PDF]
, 2015 Timothy S Leung,1 Ernest H Law2 1Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada; 2Department of Pharmacy Systems, Outcomes and Policy, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA ...
Leung TS, Law EH
core
Laboratory monitoring of direct oral anticoagulants (DOACs)-The perfect storm?
, 2017 Laboratory monitoring of direct oral anticoagulants ...
LIPPI, Giuseppe, Favaloro, Emmanuel J.
core +1 more source
European Journal of Case Reports in Internal MedicineA floating thrombus in the thoracic aorta represents a rare vascular condition frequently associated with morbidity and mortality. There is no standardised management approach, but options potentially include anticoagulation therapy, surgical ...
Joshua Hermiz +5 more
doaj +1 more source
Bioactive Natural Products in Cardiovascular Disease: Focus on Thrombotic Events
Phytotherapy Research, EarlyView.An overview of the role of natural products (NP) in cardiovascular disease prevention, highlighting key mechanisms of action: including antiplatelet, antithrombotic, anti‐inflammatory, and antioxidant effects. Additionally, it illustrates the integration of diet–drug interactions, nutritional epigenetics, and the role of artificial intelligence in ...
Maria Nektaria Magkoulia +1 more
wiley +1 more source
DOACs in CAT: A Systematic Review and Network Meta-Analysis
, 2020 A network meta-analysis to evaluate efficacy and safety of different direct oral anticoagulants (DOACs) when compared to low molecular weight heparin (LMWH) in cancer associated thrombosis ...
Syed Arsalan Ahmed Naqvi
core +1 more source
Frontiers in Aging Neuroscience, 2022 Direct oral anticoagulants (DOACs) are commonly prescribed with antidepressants that may increase bleeding risk. Here we assessed the association between DOACs with and without concurrent antidepressants and major bleeding risk in patients with atrial ...
Kuo-Hsuan Chang +15 more
doaj +1 more source